Filing Details
- Accession Number:
- 0001415889-21-004374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-13 20:33:18
- Reporting Period:
- 2021-09-09
- Accepted Time:
- 2021-09-13 20:33:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1697362 | Burkes Michael Brophy | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-09 | 3,021 | $0.00 | 100,776 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-09-09 | 12,500 | $0.00 | 113,276 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-09-10 | 6,188 | $119.53 | 107,088 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2021-09-09 | 3,021 | $0.00 | 3,021 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-09-09 | 12,500 | $0.00 | 12,500 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,042 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of these shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
- The RSUs vest over four years. 25% of the RSUs vested on March 9, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.
- On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of Common Stock which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. On September 9, 2021, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of Common Stock.